When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   e. Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of ...

3. Which Medications Are FDA-Approved for Weight Loss? - AOL

   www.aol.com/medications-fda-approved-weight-loss...

   It’s not uncommon to see medications approved for the treatment of other health conditions (such as type 2 diabetes) being used to help with obesity. When medications are used to treat a ...

4. Semaglutide - Wikipedia

   en.wikipedia.org/wiki/Semaglutide

   In December 2016, the US FDA New Drug Application (NDA) was filed, and in October 2017, the FDA Advisory Committee approved it unanimously. [52] In December 2017, the injectable version with the brand name Ozempic was approved for use by people with diabetes in the United States, [26] [53] and, in January 2018, in Canada. [54]

5. What you should know about the latest obesity medication ...

   www.aol.com/news/obesity-medication-zepbound...

   The US Food and Drug Administration approved the medication Zepbound last week to treat chronic obesity. The injectable drug, made by the pharmaceutical company Eli Lilly, has the active ...

6. FDA approves weight loss drug from Eli Lilly that helped ...

   www.aol.com/news/fda-approves-weight-loss-drug...

   November 8, 2023 at 12:43 PM. AJ Mast. The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help ...

7. GLP-1 receptor agonist - Wikipedia

   en.wikipedia.org/wiki/GLP-1_receptor_agonist

   The 2022 American Diabetes Association standards of medical care recommend GLP-1 agonists as a first line therapy for type 2 diabetes, specifically in patients with atherosclerotic cardiovascular disease or obesity. The drugs were also noted to reduce food intake and body weight significantly, and some have also been approved to treat obesity ...